
Alvitrox S 500mg/250mg Injection
Marketer
Alarius Healthcare
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Alvitrox S 500mg/250mg Injection
Combiflox 500mg/250mg Injection, a dual-action antibiotic, combats diverse bacterial infections by hindering microbial proliferation. Administration must be solely under a physician's guidance; strict adherence to the prescribed schedule is vital, completing the entire course regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) require emergency care. Inform your doctor of all current medications, particularly if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, drowsiness or dizziness mandates abstention from driving. Adequate rest, nutritious food, and hydration are crucial for optimal recovery. Your doctor may order blood tests and other diagnostics to monitor treatment response.
Uses of Alvitrox S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Alvitrox S 500mg/250mg Injection:
This medication will be administered by your physician or their registered nurse; self-medication is strictly prohibited.
Common Side effects of Alvitrox S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Alvitrox S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Alvitrox S 500mg/250mg Injection works:
Alvitrox S Injection (500mg Ceftriaxone/250mg Sulbactam) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam counteracts bacterial resistance, thereby boosting Ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alvitrox S 500mg/250mg Injection's concurrent use with alcohol presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Alvitrox S, 500mg/250mg, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
The administration of Alvitrox S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Alvitrox S 500mg/250mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Alvitrox S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable formulation Alvitrox S (500mg/250mg) requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alterations for Alvitrox S (500mg/250mg) injection are unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Alvitrox S 500mg/250mg Injection :
Omitting a scheduled Alvitrox S 500mg/250mg Injection requires contacting your physician.
Facts to Know About Alvitrox S 500mg/250mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Antimicrobial Agents |
